Stocktoria
Camp4 Therapeutics Corp CAMP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-10-11
Chart by TradingView
3/9
Piotroski F — financial health
-4.88
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $3.5M | $652,000 | $350,000 |
| Operating income | -$52.6M | -$53.1M | -$51.9M |
| Net income | -$80.4M | -$51.8M | -$49.3M |
| Operating cash flow | -$29.6M | -$45.6M | -$44.2M |
| Free cash flow | -$29.8M | -$46.0M | -$44.8M |
| Total assets | $117.8M | $78.3M | $54.9M |
| Total liabilities | $70.1M | $15.2M | $16.5M |
| Shareholders' equity | $47.7M | $63.1M | -$123.7M |
| Ratios | |||
| Operating margin | -1502.4% | -8142.3% | -14822.6% |
| Net margin | -2298.5% | -7943.4% | -14083.1% |
| FCF margin | -852.8% | -7055.7% | -12809.4% |
| Return on assets | -68.2% | -66.1% | -89.7% |
| Return on equity | -168.5% | -82.0% | 39.8% |
| Current ratio | 7.35 | 6.92 | 5.13 |
| Revenue growth | 436.5% | 86.3% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 17,326 | $76,408 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -4.88 (distress)
- Working capital / assets 0.837
- Retained earnings / assets -2.48
- EBIT / assets -0.446
- Equity / liabilities 0.68
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001736730 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.